HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pier Capital, LLC 131,905$5,038,7710.81%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 62,200$2,376,0400.80%
ArrowMark Colorado Holdings LLC 1,527,713$58,358,6370.71%
China Universal Asset Management Co., Ltd. 59,244$2,2630.66%
KENNEDY CAPITAL MANAGEMENT LLC 646,475$24,695,3450.60%
WASHINGTON CAPITAL MANAGEMENT, INC 15,500$592,1000.54%
MIZUHO MARKETS AMERICAS LLC 402,663$15,381,7270.54%
Artisan Partners Limited Partnership 7,712,874$294,631,7870.50%
Vivaldi Capital Management LP 35,078$1,339,9800.44%
OAK RIDGE INVESTMENTS LLC 81,757$3,123,1170.40%
AFFINITY INVESTMENT ADVISORS, LLC 15,706$599,9690.39%
Linden Thomas Advisory Services, LLC 42,450$1,621,5900.36%
KORNITZER CAPITAL MANAGEMENT INC /KS 451,524$17,248,2170.36%
AMI ASSET MANAGEMENT CORP 148,238$5,662,6810.35%
Knights of Columbus Asset Advisors LLC 93,293$3,563,7930.32%
Birchview Capital, LP 10,000$382,0000.32%
CABOT WEALTH MANAGEMENT INC 46,148$1,7630.27%
DRIEHAUS CAPITAL MANAGEMENT LLC 520,776$19,893,6430.26%
CASTLEARK MANAGEMENT LLC 127,750$4,880,0500.25%
Samalin Investment Counsel, LLC 10,757$410,8980.24%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.